Fumaric Acid

Fumaric Acid

SCHEMBL990090

CN1C2CCC1CC(Nc1ccc(-c3cccc4[nH]ccc34)nc1)C2.O=C(O)/C=C/C(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KCNH2 known ✓ Q12809 2/20 0.39
CHRNA7 P36544 4/20 0.42
PIK3CA P42336 1/20 0.42
MTOR P42345 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
HTR3A P46098 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
HPGDS O60760 4/20 0.38
JAK1 P23458 1/20 0.37
ABL1 P00519 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL990089 1.00 CHRNA7 (0.42) CHRNA7PIK3CAMTORKDM4EKCNH2
SCHEMBL744342 0.92 CHRNA7 (0.48) CHRNA7PIK3CAMTORKCNH2HTR3E
SCHEMBL744343 0.92 CHRNA7 (0.48) CHRNA7PIK3CAMTORKCNH2HTR3E
Fumaric Acid SCHEMBL747078 0.86 CHRNA7 (0.41) CHRNA7KDM4EKCNH2HTR3EHTR3B
Fumaric Acid SCHEMBL747077 0.86 CHRNA7 (0.41) CHRNA7KDM4EKCNH2HTR3EHTR3B
Fumaric Acid SCHEMBL748438 0.77 CHRNA7 (0.46) CHRNA7PIK3CAMTORKDM4EKCNH2
SCHEMBL746814 0.77 CHRNA7 (0.45) CHRNA7KCNH2HTR3EHTR3BHTR3A
SCHEMBL746815 0.77 CHRNA7 (0.45) CHRNA7KCNH2HTR3EHTR3BHTR3A
SCHEMBL747644 0.76 HPGDS (0.53) CHRNA7KCNH2HPGDSABL1
SCHEMBL747645 0.76 HPGDS (0.53) CHRNA7KCNH2HPGDSABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2431368-B1 CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives ABBVIE BAHAMAS LTD (BS) 2014-08-27 EP disclosed
EP-2018380-B1 Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives ABBOTT LAB (US) 2011-10-19 EP disclosed
US-7872017-B2 Fused bicycloheterocycle substituted azabicyclic alkane derivatives ABBOTT LABORATORIES (US) 2011-01-18 US disclosed
US-20100305089-A1 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives ABBOTT LABORATORIES (US) 2010-12-02 US disclosed
US-20080045539-A1 FUSED BICYCLOHETEROCYCLE SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES ABBVIE INC. 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045539-A1 FUSED BICYCLOHETEROCYCLE SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES MALT1, BMP2, ALKBH2 KCNH2 708/4885CHRNA7 2776/4885PIK3CA 588/4885
US-20100305089-A1 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives MALT1, BMP2, ALKBH2 KCNH2 708/4885CHRNA7 2776/4885PIK3CA 588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.